Insights on the T-Cell Therapy Global Market to 2035
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapy Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key...
Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapy Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key...
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2023" report has been...
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "CAR T-Cell therapy Market By Drug type, By Indication, By End user: Global Opportunity Analysis and...
A new study in the journal Viruses examines the phenomenon of breakthrough infections due to the evasion of T-cell immunity by the Omicron BA.4/BA.5 subvariants, showing this to be due to spike gene mutations.
In a recent study published in the journal Science Translational Medicine, researchers reported that long-term anosmia following coronavirus disease 2019 (COVID-19) could be a result of persistent T-cell mediated inflammation occurring in the olfactory epithelium even after the elimination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the olfactory tissue.